AGENDA
December 2021 Oncology Investor Conference
June 2022 Agenda to Be Released 6/13
TUESDAY, DECEMBER 7
All Times are EST Time Zone
9:00am // OPENING REMARKS
9:10am // KEYNOTE TALK - Ron DePinho, M.D., Professor of Cancer Biology | Immediate Past President MD Anderson. Topic: A Model for Converting Discovery into Impact
9:40am // Corporate Presentation - Impact Therapeutics
10:00am // Corporate Presentation - ExoProTher
10:20am // Corporate Presentation - Colospan
10:40am // Corporate Presentation - Propella Therapeutics
11:00am // Corporate Presentation - Atrin Pharmaceuticals
11:20am // Corporate Presentation - RubrcYc Therapeutics
11:40am // Corporate Presentation - SIWA Therapeutics
12:00pm // Corporate Presentation - Plus Therapeutics
12:20pm // CRO Sponsor Presentation - Nuvisan
12:40pm // SPEAKER - Wei Zhang, Ph.D., Director, Center for Cancer Genomics and Precision Oncology, Wake Forest Baptist Comprehensive Cancer Center. Topic: Precision Cancer Medicine - Targeting DNA Repair Defects
1:10pm // Corporate Presentation - AIVITA Biomedical
1:30pm // Corporate Presentation - Maxwell Biosciences
1:50pm // Corporate Presentation - Biocept
2:10pm // Corporate Presentation - KisoJi Biotechnologies
2:30pm // Corporate Presentation - BriaCell Therapeutics
2:50pm // Corporate Presentation - TransCode Therapeutics
3:10pm // Corporate Presentation - TargaZyme
3:30pm // SPEAKER - Corrie Painter, Ph.D., Associate Director of the Broad Institute Cancer Program | Associate Director of Count Me In. Topic:Count Me In: Partnering with Patients to Accelerate the Pace of Discoveries
4:00pm // CLOSING REMARKS
WEDNESDAY, DECEMBER 8
All Times are EST Time Zone
9:00am // OPENING REMARKS
9:10am // SPEAKER - Alfred Slanetz, Ph.D., President and CEO of Geneius Biotechnology | Former CEO, Bluebird Bio | Board of Directors NFCR. Topic: T-Cell Therapies for Cancer
9:40am // Corporate Presentation - Altamira Therapeutics
10:00am // Corporate Presentation - Curadigm
10:20am // Corporate Presentation - Early Detection
10:40am // Corporate Presentation - SFA Therapeutics
11:00am // Corporate Presentation - Bexion Pharmaceuticals
11:20am // Corporate Presentation - Qu Biologics
11:40am // Corporate Presentation - CytoImmune Therapeutics
12:00pm // Corporate Presentation - Siva Therapeutics
12:20pm // SPEAKERS - Steven Ferguson, Deputy Director, Licensing and Entrepreneurship, NIH. Michael Salgaller, Ph.D., Director of Tech Transfer, NCI | Supervisor, Invention Development and Marketing Unit (IDMU). Topic: Buying into the Buy Side: NIH as an Industry Partner for Your Go-to-Market Strategy
12:50pm // Corporate Presentation - Carina AI
1:10pm // Corporate Presentation - 7 Hills Pharma
1:30pm // Corporate Presentation - Revere Pharmaceuticals
1:50pm // Corporate Presentation - OncoOne
2:10pm // Corporate Presentation - AmMax Bio
2:30pm // Corporate Presentation - Rakovina Therapeutics
2:50pm // Corporate Presentation - Propelle Therapeutics
3:10pm // Corporate Presentation - Nammi Therapeutics
3:30pm // Corporate Presentation - Creatv MicroTech
3:50pm // SPEAKER - Abraham Heifets, Ph.D., CEO and Co-Founder of Atomwise. Topic: World's Largest Prospetive Application of Machine Learning to Small Molecule Hit Discovery
4:20pm // CLOSING REMARKS
THURSDAY, DECEMBER 9
All Times are EST Time Zone
9:00am // OPENING REMARKS
9:10am // KEYNOTE TALK - Christiana Bardon, M.D., Partner, MPM Capital and MPM Oncology Impact Fund | Co-Managing Partner of BioImpact Capital. Topic: Oncology: The Smartest Investment in Biotech
9:40am // Corporate Presentation - Transcenta
10:00am // Corporate Presentation - Radiopharm Theranostics
10:20am // Corporate Presentation - Silenseed
10:40am // Corporate Presentation - Infinitum Health
11:00am // Corporate Presentation - Monopteros Therapeutics
11:20am // Corporate Presentation - Brooklyn ImmunoTherapeutics
11:40am // Corporate Presentation - Advanced Microbubbles
12:00pm // SPEAKER - Brian Leyland-Jones, M.D., Ph.D., Former Director of Emory and McGill Cancer Centers | CMO, NFCR | Director, The Darwin Foundation. Topic: The Death Of Cancer!
12:30pm // Corporate Presentation - NuVox Pharma
12:50pm // Corporate Presentation - TarMeta BioSciences
1:10pm // Corporate Presentation - Felicitex Therapeutics
1:30pm // Corporate Presentation - SciTech Development
1:50pm // Corporate Presentation - Vivan Therapeutics
2:10pm // Corporate Presentation - Neosoma
2:30pm // Corporate Presentation - GeoVax
2:50 // Corporate Presentation - Kintara Therapeutics
3:10pm // Corporate Presentation - SageMedic
3:30pm // SPEAKER - Phil Freidlander, M.D., Ph.D., Professor of Medicine, Hematology and Medical Oncology, Mt. Sinai. Topic: Recent Development on TILs and Summary Report of Iovance Data
4:00pm // KEYNOTE SPEAKER - Roy Herbst, M.D., Ph.D., Head Medical Oncology, Yale | Former Director, Yale Cancer Center. Topic: Checkpoint Inhibitors
4:30pm // CLOSING REMARKS